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● Intraocular Pressure (IOP) outcomes for ab interno trabeculectomy with 
the Trabectome (T), a minimally invasive glaucoma surgery, have had 
relatively similar IOP results to trabeculectomy.[i,ii]  
● T rarely causes serious complications and has about 10 times less non-
serious complications compared to trabeculectomy or aqueous shunts 
and serious complications occur in <1%.[iii]
● Because of the above, we are now using T also in moderate to very 
advanced glaucoma for initial surgeries.
● No manuscript has yet compared IOP outcomes of T to Ahmed 
Glaucoma Implants (AGI).
Case-Matched Results of Trabectome Ab Interno 
Trabeculectomy versus Ahmed Glaucoma Implant
● Retrospective study of outcomes of T (n=103) to AGI (n=41) up to 1 year.
● Cases were matched with propensity-score matching using a genetic 
algorithm based on age, gender, type of glaucoma, concurrent 
phacoemulsification, and baseline IOP and medications. Cases of T or 
AGI too different from their counterparts were excluded.
● Procedures were performed by the same group of surgeons on 
comparable patient populations for primary and secondary open angle 
glaucomas and chronic angle closure.
● Exclusion criteria consisted of neovascular glaucoma.
● IOP and number of medications were compared with a non-paired 
Student’s t-test and considered significant if p<0.05.
● T and AGI had similar IOPs for the first 6 months.
● At 12 months, the IOP was 4.7 mmHg lower with AGI than with T, p<0.01 
but with twice as many medications.
● This further IOP decrease with AGI had a reintervention rate that was 5.9 
times more frequent.
● In contrast to AGI, patients who underwent T had no serious 
complications.
● T offered a safer alternative to a mean final IOP of 16.4±6.2 mmHg, 42% 
lower than baseline.
● Prior to matching, T had a preoperative IOP of 20.8±8.1 mmHg on 2.7±1.8 
medications. After 1 year, the number of medications decreased to 1.9±1.7.
● Prior to matching, AGI had a preoperative IOP of 30.0±13.4 mmHg on 3.0±1.4 
medications. After 1 year, the number of medications increased to 4.2±1.6.
● After matching, there was no significant difference in IOP between AIT and AGI at 1 
week, 1 month, 3 months and 6 months (all p>0.05).
● At 1 year, matched T (n=14) had a baseline IOP of 28.1±9.2 mmHg that decreased to 
16.4±6.2 mmHg (42% decrease) compared to AGI (n=11) with a baseline of 26.9±8.5 
mmHg that decreased to 11.7±4.5 mmHg (57% decrease, p<0.01).
● In T, transient cystoid macular edema (CME) occurred in 0.8% and 16% required 
further surgery. In AGI, there were choroidal effusions in 7% and 41% required further 
interventions.
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     Trabectome
● 1 year IOP ~ 15 mmHg
● fast, safe
● no permanent hardware
● needs clear cornea
● significant learning curve
Ahmed
● 1 year IOP ~ 17 mmHg
● valved = fast IOP drop  but 
can obstruct
● works well in uveitis
● tube can erode
● After 12 months, AGI had a lower average IOP. AGI required more 
secondary interventions.
● Results of this study will allow informed design of RCTs or larger studies 
that can also match for medication strategies and justify crossover in case 
of failure.
● To compare the IOP reduction, number of medications, and complications 
after trabecular meshwork ablation with T vs trabecular bypass with the 
AGI.
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 # Days 
Post-Op
T, 
n
T Delta IOP 
(mmHg)
AGI, 
n
AGI Delta IOP 
(mmHg) p-value
90 32 10.7±8.1 33 11.4±10.1 p>0.05
180 24 9.3±7.4 19 11.2±8.6 p>0.05
270 10 8.8±0.0 7 14.6±11.7 p>0.05
360 14 11.7±6.8 11 15.2±7.2 p<0.01
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